Stay updated on Vertex Pharmaceuticals Press Releases

Sign up to get notified when there's something new on the Vertex Pharmaceuticals Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Vertex Pharmaceuticals Press Releases page

  1. Check
    5 days ago
    Change Detected
    Summary
    The webpage has been updated to include new financial results and clinical study announcements from Vertex, while previous announcements regarding advancements in pain treatment and a licensing agreement have been removed.
    Difference
    7%
    Check dated 2025-08-06T18:42:47.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Vertex has been recognized as a winner at the Premier, Inc. Breakthroughs Innovation Celebration for its non-opioid treatment JOURNAVX™, and has secured a broad reimbursement agreement with NHS England for ALYFTREK®, a new treatment for cystic fibrosis.
    Difference
    8%
    Check dated 2025-07-16T09:25:28.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The page has updated its financial results announcement date and removed a previous clinical trial update.
    Difference
    4%
    Check dated 2025-07-09T05:57:26.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The page now includes an announcement regarding the European Commission's approval of ALYFTREK, a new treatment for cystic fibrosis, while the previous announcement about FDA clearance for VX-407 has been removed.
    Difference
    5%
    Check dated 2025-07-02T01:58:31.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The webpage has added significant updates regarding Vertex's positive data for Zimislecel in Type 1 Diabetes and a strategic agreement with Ono Pharmaceutical, while removing previous announcements about investor conferences and a positive opinion for KALYDECO.
    Difference
    8%
    Check dated 2025-06-24T21:50:53.000Z thumbnail image
  8. Check
    55 days ago
    Change Detected
    Summary
    The page has updated its content to include new information about CASGEVY presented at the 2025 EHA Congress, while removing a previous announcement regarding the European Commission's approval of the therapy.
    Difference
    5%
    Check dated 2025-06-17T15:51:11.000Z thumbnail image

Stay in the know with updates to Vertex Pharmaceuticals Press Releases

Enter your email address, and we'll notify you when there's something new on the Vertex Pharmaceuticals Press Releases page.